Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
C$1.32
+5.6%
C$1.32
C$0.80
C$4.06
C$256.62MN/A1.51 million shs310,601 shs
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shs7,500 shs
Almirall, S.A. stock logo
LBTSF
Almirall
$15.35
$15.35
$13.36
$15.47
N/AN/A200 shsN/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
$59.91
-5.4%
$57.83
$52.10
$75.97
N/AN/A1,611 shs81 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Almirall, S.A. stock logo
LBTSF
Almirall
0.00%0.00%0.00%-0.78%+70.37%
Novozymes A/S stock logo
NVZMF
Novozymes A/S
-5.42%+0.45%-0.03%+0.10%-3.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
C$1.32
+5.6%
C$1.32
C$0.80
C$4.06
C$256.62MN/A1.51 million shs310,601 shs
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shs7,500 shs
Almirall, S.A. stock logo
LBTSF
Almirall
$15.35
$15.35
$13.36
$15.47
N/AN/A200 shsN/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
$59.91
-5.4%
$57.83
$52.10
$75.97
N/AN/A1,611 shs81 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Almirall, S.A. stock logo
LBTSF
Almirall
0.00%0.00%0.00%-0.78%+70.37%
Novozymes A/S stock logo
NVZMF
Novozymes A/S
-5.42%+0.45%-0.03%+0.10%-3.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00
N/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00
N/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
2.00
HoldN/AN/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/AN/AN/AN/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A-$0.16N/AN/AN/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/A-$0.07N/AN/AN/AN/AN/AN/A5/11/2026 (Estimated)
Novozymes A/S stock logo
NVZMF
Novozymes A/S
N/A$8.027.47N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/AN/AN/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
$1.803.00%N/A22.44%N/A

Institutional Ownership

CompanyInstitutional Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
32.45%
Almirall, S.A. stock logo
LBTSF
Almirall
16.10%
Novozymes A/S stock logo
NVZMF
Novozymes A/S
20.41%

Insider Ownership

CompanyInsider Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/A
Novozymes A/S stock logo
NVZMF
Novozymes A/S
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A194.41 millionN/ANot Optionable
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Almirall, S.A. stock logo
LBTSF
Almirall
1,996N/AN/ANot Optionable
Novozymes A/S stock logo
NVZMF
Novozymes A/S
10,452N/AN/ANot Optionable

Recent News About These Companies

Novonesis (Novozymes A/S): Interim report Q1 2026
Novozymes A/S (NVZMF) Projected to Post Earnings on Tuesday
Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript
Resolutions from the Annual General Meeting 2025
Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript
Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript
Novozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript
Novonesis A/S Series B
Novozymes A/S (NZM2.BE)
Trading by management and close relations of management
Recap: Novozymes Q4 Earnings

Media Sentiment Over Time

VIVO Cannabis stock logo

VIVO Cannabis CVE:ABCN

C$1.32 +0.07 (+5.60%)
As of 08/3/2018

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals stock logo

Abattis Bioceuticals OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Almirall stock logo

Almirall OTCMKTS:LBTSF

$15.35 0.00 (0.00%)
As of 05/4/2026

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Novozymes A/S stock logo

Novozymes A/S OTCMKTS:NVZMF

$59.91 -3.44 (-5.42%)
As of 05/6/2026 03:11 PM Eastern

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.